Abstract Emerging SARS-CoV-2 variants, notably Omicron, continue to remain a formidable
challenge to worldwide public health. The SARS-CoV-2 receptor-binding domain (RBD) is a …

While humoral immune responses to infection or vaccination with ancestral SARS-CoV-2
have been well-characterized, responses elicited by infection with variants are less …

The coronavirus disease 2019 (COVID-19) has persisted as a pandemic for just over two
years; vaccines have been developed to prevent the clinical disease and treatment …

In the past two years, the global research in combating COVID-19 pandemic has led to
isolation and characterization of numerous human antibodies to the SARS-CoV-2 spike …

A more efficient and effective adaptive humoral immune response has been proposed as the
basis of the usually favourable outcome of paediatric COVID-19. The breadth of virus and …

This study explores the infectivity of SARS-CoV-2 and its implications for immune evasion,
resulting in significant variants carrying mutations that facilitate evasion from host cells. As …

Antibodies produced by B cells are diverse molecules that bind and neutralize foreign
antigens with high specificity and serve as a critical component of adaptive immunity …

The COVID-19 pandemic incited an unprecedented demand for novel drug therapeutics,
and in doing so, highlighted the shortcomings of therapeutic monoclonal antibody …